Blood Testing: Technologies and Global Markets

Report Highlights

The global market for blood testing will grow from nearly $53.8 billion in 2018 to $60.5 billion by 2023 with a compound annual growth rate (CAGR) of 2.4% for the period of 2018-2023.

Report Includes

• 35 data tables and 43 additional tables
• Country specific data and analysis for US, Canada, Mexico, Germany, France, UK, Italy, Spain, Portugal, China, India, Japan, South Korea and Australia
• Analysis of the global market for blood testing, using quantitative and qualitative approaches
• Description of blood tests that are routinely used for evaluating, screening and monitoring by using analysers (including automated analysers) and integrated systems
• Coverage of methods of extraction of blood for blood testing, and discussion of advantages and disadvantages of blood tests
• Detailed study of the regulatory and reimbursement aspect of the industry
• Insight into current trends and recent developments in the blood testing market
• Comprehensive company profiles of major players in the industry, including Abbott Laboratories, Biomérieux Marcy L’etoile, F. Hoffman-La Roche Ag, Nova Biomedical Corp., Siemens Healthineers, Thermo Fisher Scientific

Report Scope

This study covers the blood tests that are used routinely for screening, monitoring and evaluating by using analyzers (including automated analyzers) and integrated systems. This report also covers home-monitoring devices and test strips and the associated calibration reagents for diabetes and lipid profiles using finger pricks. The report analyzes and assesses therapeutic and screening applications of blood tests for human conditions such as diabetes, heart disease, autoimmune disorders, cancer, blood disorders, hormonal imbalances, infection and pregnancy. Excluded from this study are urinalysis, urine home diagnostic kits and diagnostic testing such as imaging as well as veterinary blood tests and their analyzers.

The report also includes a discussion of the market’s major drivers and global dynamics along with the political, economic, social and technological factors that impact the market. The report provides market size estimates for the year 2017 (considered as a base year) and 2018, as well as a forecast through 2023. Market estimates and forecast figures are provided for all major market segments. A discussion of the major players is included in the competitive landscape section, which provides trends in product launches, collaborations, mergers and acquisitions, and other agreements.

The report concludes with a special focus on company profiles and includes detailed profiles of the major vendors in the blood testing market.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

• Siemens: 360° Company Analysis (IFT322A)
• Thermo Fisher Scientific Inc.: 360° Company Analysis (HLC309A)
• Needle-Free Devices: Technologies and Global Markets (HLC178C)
• Koninklijke Philips N.V.: 360° Company Analysis (HLC308A)
• Global High Purity Quartz Market (CHM191A)